• Biogen Seeks Dialogue With US CMS About Alzheimer's Drug Coverage Decision

    9 days ago - By Medscape

    Biogen's chief executive officer on Thursday said the company wants a dialogue with the CMS ahead of a final decision on coverage of its controversial Alzheimer's disease drug in April.
    Reuters Health Information
    Read more ...